Back to Peptide Deep Dives
Peptide Deep Dives•••16 min read

What Is Glutathione? How It Works, Benefits, and Risks

What glutathione is, how this antioxidant works, oral vs liposomal vs IV evidence, side effects and cons, and what human studies actually show.

PeptIQ Team
Peptide Research & Education
What Is Glutathione? Benefits, Risks & Evidence

PeptIQ app

Track your peptide protocols in PeptIQ

Log injections, vial supply, and reminders. Use peptiq.io calculators when you need math on the web.

Get the appOpen web app

iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

TL;DR

Glutathione is a tripeptide your body makes from three amino acids: glutamate, cysteine, and glycine. It helps cells manage oxidative stress, supports detoxification pathways, and plays a role in immune and cellular signaling. People also buy it as an oral supplement, a liposomal product, or an intravenous (IV) or injectable treatment.

Those uses are not interchangeable, and the evidence is uneven:

  • Being essential is not the same as proving that adding more helps. Glutathione is abundant inside healthy cells. A low or altered level can show up in many illnesses, but that does not automatically mean a supplement or infusion will treat the illness.
  • Oral evidence is mixed. A six-month randomized trial in healthy adults found that oral glutathione raised glutathione stores in blood and other cells, and those levels fell back after a washout. A shorter four-week trial did not change glutathione status or oxidative-stress markers.
  • Liposomal and sublingual forms have only small, short studies. They are preliminary, not proof of broad health benefits.
  • IV glutathione has been studied in a few medical settings, with modest or unclear results. For cosmetic skin lightening, reviewers have found no adequate safety data for chronic IV use. U.S. FDA alerts in 2019 and 2026 described serious reactions, including hospitalizations, after compounded injectable glutathione made from dietary-supplement-grade ingredients.
  • Inhaled (nebulized) glutathione can narrow the airways in people with asthma.

This PeptIQ.io guide was written on November 16, 2026 from published research and FDA communications. It is education, not a treatment plan, and it does not tell you how much to take or where to buy it.

Talk with a licensed clinician before starting, stopping, or changing any glutathione product or related supplement.

What Is Glutathione?

Glutathione is a naturally occurring tripeptide, meaning a chain of three amino acids: glutamate, cysteine, and glycine. Chemists sometimes write it as gamma-glutamyl-cysteinyl-glycine, or GSH for the reduced form that does most of the protective work.

It is not a social-media "research peptide" in the usual sense. You do not need a clinic to have glutathione. Almost every cell in the body makes it, and the liver is an especially important site of production and use. Inside cells it is one of the most abundant small thiol (sulfur-containing) molecules, and the balance between reduced glutathione (GSH) and its oxidized partner (GSSG) is a major part of the cell's redox system. A 2009 review in Molecular Aspects of Medicine and a 2013 review in Biochimica et Biophysica Acta describe those core roles and how synthesis is controlled. (Forman, Zhang, and Rinna, 2009; Lu, 2013)

When people say "glutathione," they may mean any of these:

  • The molecule your cells already make
  • An oral dietary supplement
  • A liposomal or sublingual product designed to change absorption
  • A compounded IV or injectable product given in a clinic
  • An inhaled or topical product
  • A precursor, such as the amino acid cysteine or the medicine N-acetylcysteine (NAC), which the body can use to make more glutathione

Those are different interventions. A finding about one of them should not be used to advertise another.

What It Does

Reviews of glutathione physiology generally group its work into a few jobs:

  • Antioxidant defense. Enzymes called glutathione peroxidases use GSH to neutralize hydrogen peroxide and related compounds, which helps limit oxidative damage to fats, proteins, and DNA.
  • Recycling other antioxidants. Glutathione helps regenerate oxidized forms of nutrients such as vitamin C and vitamin E, so those molecules can keep working.
  • Detoxification. Glutathione S-transferases attach glutathione to certain drugs, pollutants, and metabolic byproducts so they can be cleared. This is one reason the liver is so rich in glutathione.
  • Cellular housekeeping and signaling. Glutathione status is involved in cell growth, cell death, immune signaling, and a process called protein glutathionylation, in which glutathione temporarily tags proteins and changes their activity.

A 2004 review in The Journal of Nutrition summarizes these roles and notes that glutathione deficiency and oxidative stress show up across many diseases. That is an observation about biology, not a claim that glutathione supplements treat those diseases. (Wu et al., 2004)

How It Works

Your cells build glutathione in the cytosol, the fluid inside the cell, in two enzyme steps. The first and rate-limiting enzyme is glutamate-cysteine ligase (also called gamma-glutamylcysteine synthetase). The second is glutathione synthetase. Two things usually control how much glutathione a cell can make: how much cysteine is available, and how active that first enzyme is. The finished molecule can also turn its own production down through feedback inhibition. (Wu et al., 2004; Lu, 2013)

Once made, reduced glutathione (GSH) donates electrons to help neutralize oxidants. In that process, two GSH molecules are linked to form oxidized glutathione (GSSG). An enzyme called glutathione reductase, using NADPH, can convert GSSG back to GSH so the pool can be reused. When glutathione is used to tag and export a toxin, that glutathione is consumed rather than recycled.

This is why "boosting glutathione" is more complicated than it sounds. The body already tightly regulates the pool. Providing more of the finished molecule, providing a precursor such as cysteine or NAC, or changing diet and illness can all affect levels in different ways. NAC is a cysteine prodrug with a well-established medical use as an antidote in acetaminophen (paracetamol) overdose, and it has been studied in other glutathione-related conditions. That medical evidence should not be copied onto over-the-counter glutathione products. (Atkuri et al., 2007)

A 2019 narrative review in Nutrients also discusses food, amino acids, vitamins, and other dietary factors that may influence glutathione status, while noting that clear causal links to disease prevention are still being worked out and that genetics can change a person's response. (Minich and Brown, 2019)

Forms: Oral, Liposomal, IV, and Others

FormWhat it isWhat the human evidence is like
Oral capsules or tabletsSwallowed glutathioneMixed results on whether blood and tissue stores rise
Liposomal oralGlutathione in a lipid (fat) coating, meant to improve uptakeOne small, short pilot found rises in body stores and some immune markers
SublingualHeld under the tongueOne small crossover study reported higher plasma glutathione than swallowed glutathione
IV or injectableGiven by vein or injection, usually compoundedBypasses digestion; clinical results are limited, and quality and safety problems have been documented
Inhaled (nebulized)Breathed into the lungsCan cause airway narrowing in people with mild asthma
TopicalCreams or lotions, often marketed for skin toneSmall studies; a systematic review found the skin-lightening evidence inconclusive
Precursors (for example NAC or cysteine)Building blocks the body can use to make glutathioneDifferent compounds with their own evidence, including approved medical uses for NAC

Oral glutathione

For years, a common claim was that swallowed glutathione could not raise body stores because it is broken down in the gut. Human trials do not all agree.

In 2011, Allen and Bradley ran a randomized, double-blind, placebo-controlled trial in 40 healthy adults. After four weeks of oral glutathione, there was no significant change in urinary oxidative-stress markers or in red-blood-cell glutathione, including the reduced and oxidized forms and their ratio, compared with placebo. (Allen and Bradley, 2011)

In 2015, Richie and colleagues published a six-month randomized, double-blind, placebo-controlled trial in 54 healthy nonsmoking adults. Oral glutathione, tested at two daily amounts, increased glutathione in blood, red cells, plasma, and lymphocytes, with larger changes at the higher amount. In the higher-amount group, mean glutathione was about 30% to 35% higher in red cells, plasma, and lymphocytes at six months, and much higher in cheek cells. Levels returned to baseline after a one-month washout. The trial also reported a reduction in some oxidative-stress measures and explored immune markers in a subset of participants. (Richie et al., 2015)

A 2014 study in Journal of Agricultural and Food Chemistry found an increase in the protein-bound form of glutathione in human blood after oral administration, which is another way researchers have tried to track whether the molecule is absorbed. (Park et al., 2014)

Taken together, the oral research suggests that duration, the amount studied, and what is measured all matter. A rise in blood glutathione is a laboratory finding. It is not, by itself, proof of better energy, longer life, clearer skin, or a healthier liver.

Liposomal and sublingual products

A one-month pilot study of oral liposomal glutathione in 12 healthy adults, led by the same research group as the 2015 oral trial, reported increases in glutathione in blood, red cells, plasma, and immune cells, along with lower oxidative-stress biomarkers and some changes in immune-function markers, including natural killer cell activity. The study was small and short. The published abstract does not describe a placebo group, so it should be read as preliminary. (Sinha et al., 2018)

A three-week randomized crossover study in 20 adults with metabolic syndrome compared oral glutathione, a sublingual form, and NAC. The authors reported that the sublingual form raised plasma glutathione and the GSH/GSSG ratio more than swallowed glutathione, and that vitamin E in plasma rose only in the sublingual group. That is a useful comparison, but it is still a small, short study of blood markers, not clinical outcomes. (Schmitt et al., 2015)

Intravenous and injectable glutathione

Giving glutathione by vein skips the digestive tract, so blood levels can rise quickly. That pharmacokinetic fact is sometimes marketed as if IV were automatically more effective for health. The clinical evidence does not support a blanket claim.

In Parkinson's disease, a 2009 randomized, double-blind, placebo-controlled pilot trial by Hauser and colleagues assigned 21 people to IV glutathione or placebo three times a week for four weeks. The infusions were well tolerated, and reported side effects were similar in both groups. There were no significant differences on the Unified Parkinson's Disease Rating Scale. The authors said a mild symptomatic effect remained possible and would need a larger study. (Hauser et al., 2009)

Intranasal glutathione has also been tested in Parkinson's disease. A 2017 phase IIb randomized, placebo-controlled trial in 45 people found that all groups, including the saline placebo group, improved over three months. The higher-amount group improved compared with its own baseline, but neither glutathione group beat placebo. One person in the higher-amount group developed cardiomyopathy. The authors concluded that the data did not show superiority to placebo after three months. (Mischley et al., 2017)

For cosmetic skin lightening, a 2016 review in the South African Medical Journal found no studies of IV glutathione used for that purpose, and no studies of long-term IV safety for any indication. The authors warned that a shift toward redder pheomelanin might increase sun-related skin cancer risk in people who previously had more protective pigment, and they called for regulation to protect consumers. (Davids, van Wyk, and Khumalo, 2016) Dermatology reviews have reached similar conclusions: parenteral glutathione is widely promoted for lightening, but the clinical evidence is weak, and some regulators, including the Philippine Food and Drug Administration, have issued public warnings about this off-label use. (Sonthalia et al., 2016; Sonthalia et al., 2018)

Quality is a separate issue from theory. In 2019, and again on August 27, 2026, FDA warned compounders not to use dietary-supplement-grade glutathione in injectable drugs. The 2026 communication described at least 30 patients with adverse events after IV glutathione, including fever, chills, pain, dizziness, and shock-like or sepsis-like symptoms, with some hospitalizations. The glutathione came from a dietary-supplement-grade lot that is not appropriate for injections, and two Texas compounding pharmacies recalled products because of elevated endotoxin levels. Endotoxin exposure can also cause low blood pressure, vomiting, and, in severe cases, death. FDA noted that it had already raised this concern in 2019 and that the risk was continuing. (FDA, 2019; FDA, August 27, 2026)

In the United States, oral glutathione is typically sold as a dietary supplement. Injectable products used in wellness or cosmetic clinics are usually compounded. Compounded is not the same as FDA-approved for skin lightening, energy, or anti-aging.

Inhaled and topical glutathione

A randomized, double-blind, crossover study in eight people with mild asthma found that nebulized glutathione caused substantial airway narrowing. Forced expiratory volume fell about 19% and pulmonary resistance rose about 61%, compared with much smaller changes after placebo. Some patients coughed or felt short of breath. The authors linked the effect to sulfite formation. (Marrades et al., 1997) Anyone with asthma or another lung condition should treat inhaled glutathione as a medical decision, not a casual wellness treatment.

A 2019 systematic review of glutathione and skin color included four clinical studies, mostly of oral or topical products. The authors found some brightening in sun-exposed skin in certain studies, but said the overall evidence was still inconclusive because of study quality and inconsistent results. Adverse events were reported, though not serious ones in those small trials. (Dilokthornsakul et al., 2019)

Potential Benefits, With the Evidence Attached

It helps to separate what glutathione does in cells from what a product has been shown to do in people.

What is reasonably established in physiology: glutathione is a central antioxidant and detoxification molecule. Cells need it. Diet, cysteine availability, illness, and genetics all influence how much is on hand. (Wu et al., 2004; Lu, 2013)

What some human studies have shown:

  • Longer oral supplementation can raise glutathione stores in healthy adults, at least while it is being taken. (Richie et al., 2015)
  • A small liposomal pilot and a small sublingual crossover study reported rises in glutathione-related blood markers. (Sinha et al., 2018; Schmitt et al., 2015)
  • An open-label, uncontrolled pilot in 34 people with nonalcoholic fatty liver disease reported that liver enzyme ALT fell after oral glutathione. Without a placebo group, it is hard to know how much of that change was due to the supplement. A 2023 review concluded that evidence for a therapeutic role of glutathione in this condition is still limited. (Honda et al., 2017; Santacroce et al., 2023)
  • Short oral and topical studies have reported modest, sometimes reversible changes in skin melanin index or wrinkle measures. A systematic review judged that evidence inconclusive. (Weschawalit et al., 2017; Dilokthornsakul et al., 2019)

What has not been shown: none of the studies reviewed here establishes that glutathione supplements or infusions extend human life, treat "low energy" or "brain fog" as general conditions, or are a proven cosmetic IV treatment.

Risks, Side Effects, and Other Cons

  • A higher blood level is not a health outcome. Raising glutathione in a lab test can be interesting and still fail to improve symptoms, function, or long-term risk.
  • The research base is uneven. Several of the better-known studies are small, short, uncontrolled, or limited to biomarkers in healthy volunteers. Results for oral use do not all point the same way.
  • IV and injectable products carry procedure and quality risks. Any IV infusion can cause infection, vein irritation, or allergic reaction. FDA has documented endotoxin-related illnesses, including hospitalizations, when dietary-supplement-grade glutathione was used to compound injections. (FDA, 2026)
  • IV use for skin lightening lacks adequate safety data. Reviewers have also raised a theoretical concern that a shift in melanin type could increase sun-related skin cancer risk. Some national regulators have warned the public about this use. (Davids, van Wyk, and Khumalo, 2016)
  • Inhaled glutathione can trigger bronchoconstriction in people with asthma. (Marrades et al., 1997)
  • Oral products are not risk-free just because they are swallowed. Short trials in healthy adults have often reported good tolerability, but that does not map long-term safety in people with liver, kidney, or other disease, or in pregnancy. In one oral skin study, two participants had temporary liver-enzyme elevations. (Weschawalit et al., 2017)
  • Intranasal research has not shown a clear benefit over placebo in Parkinson's disease, and one cardiomyopathy case was reported in a small trial. That single event does not prove cause, but it is a reminder that "natural" is not the same as harmless. (Mischley et al., 2017)
  • Antioxidant products are not automatically helpful for everyone. The body uses oxidant and antioxidant signals in a balance. More is not always better, and a supplement that helps one laboratory marker can be irrelevant or unhelpful in another context.

Questions to Take to a Clinician

If someone has recommended glutathione to you, these questions can make the conversation more useful:

  • What problem are we trying to address, and how would we tell whether it is working?
  • Which form is being proposed, and what human evidence exists for that form and that goal?
  • If an IV or injection is suggested, what is the source of the product, and is it an ingredient suitable for injection rather than a dietary-supplement-grade powder?
  • Do I have asthma, a lung condition, liver disease, or other issues that would change the risk?
  • Could diet, a medical evaluation, or a different, better-studied treatment address the same goal?

Frequently Asked Questions

Q: What is glutathione, in one sentence?

A: It is a small antioxidant and detoxification molecule, made from glutamate, cysteine, and glycine, that almost every human cell produces.

Q: Does taking glutathione work?

A: It depends what "work" means. Some oral studies show that body stores can rise. That is not the same as proving a benefit for aging, energy, skin tone, or liver disease. Results also differ by form and study design.

Q: Is IV glutathione better than pills?

A: IV delivery avoids digestion, but the human outcome data are limited, and compounded injectable products have been tied to serious quality problems. The research reviewed here does not establish a universal winner.

Q: What are the main side effects?

A: They depend on the route. Oral studies in healthy adults have often been well tolerated, with occasional laboratory changes. IV infusions can cause infusion reactions and, when product quality is poor, endotoxin-related illness. Inhaled glutathione can tighten the airways in people with asthma.

Q: Is glutathione FDA approved?

A: Oral products are typically sold as dietary supplements, which are not approved as drugs to treat disease. Injectable products used in clinics are usually compounded, which is not the same as FDA approval for wellness or cosmetic claims.

Q: Should I take it?

A: That is a question for a licensed clinician who knows your history. This guide is for education and does not recommend starting or stopping any product.

Related Guides

This article is educational content from PeptIQ.io. It is not medical advice. Talk with a licensed clinician before starting, stopping, or changing any peptide, medication, or injection practice.

For clinics: running peptide or GLP-1 programs for patients? See PeptIQ.io for providers: protocol templates, a patient app, and adherence tracking in one console.

Share this article

Track Your Peptide Protocols

Use PeptIQ to log injections and vial supply, use peptiq.io calculators for math on the web, and keep protocols organized.

Stay ahead of the peptide conversation

Weekly-ish notes on new research, wiki trends, and practical tracking tips. No spam — unsubscribe anytime.

Educational updates only — not medical advice. Privacy